5-chloro-2-(2-pyrazinylmethyl)aniline | 922711-57-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-chloro-2-(2-pyrazinylmethyl)aniline
• 英文别名: 5-chloro-2-(pyrazin-2-ylmethyl)aniline
• CAS: 922711-57-7
• 化学式: C₁₁H₁₀ClN₃
• 分子量: 219.673
• InChiKey: FVLXEBYTCYKURU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  51.8
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF
  申请人：Memory Pharmaceuticals Corporation

  公开号：EP1742944A1

  公开（公告）日：2007-01-17
• INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, AND PREPARATION AND USES THEREOF
  申请人：Memory Pharmaceuticals Corporation

  公开号：EP1735306A2

  公开（公告）日：2006-12-27
• 1 H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZIOSOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF
  申请人：Memory Pharmaceuticals Corporation

  公开号：EP1745046A2

  公开（公告）日：2007-01-24
• [EN] INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, AND PREPARATION AND USES THEREOF<br/>[FR] INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, ET LEUR PREPARATION ET LEURS UTILISATIONS
  申请人：MEMORY PHARM CORP

  公开号：WO2005092890A2

  公开（公告）日：2005-10-06

  The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (e.g., indazoles and benzothiazoles), which act as ligands for the a7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
• [EN] 1H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND CHROMONES AND PREPARATION AND USES THEREOF<br/>[FR] 1H-INDAZOLES, BENZOTHIAZOLES, 1,2-BENZOISOXAZOLES, 1,2-BENZOISOTHIAZOLES, ET CHROMONES, LEUR PREPARATION ET LEURS UTILISATIONS
  申请人：MEMORY PHARM CORP

  公开号：WO2005111038A2

  公开（公告）日：2005-11-24

  The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.